Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1F | O60840 | 1/20 | 0.53 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.53 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.53 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9809456 | 0.85 | CACNA1F (0.61) | CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL9809525 | 0.84 | CACNA1F (0.60) | CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL9809478 | 0.82 | CACNA1F (0.57) | CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL9809466 | 0.82 | CACNA1B (0.51) | CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7436390 | 0.81 | CACNA1F (0.56) | CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL9809562 | 0.80 | CACNA1F (0.55) | CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL9809530 | 0.79 | MAPT (0.62) | CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL9809467 | 0.79 | CACNA1F (0.61) | CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL10614366 | 0.77 | CACNA1C (0.56) | CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7434494 | 0.75 | CACNA1F (0.62) | CACNA1FCACNA1DCACNA1SCACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5075324-A | ARALKYL-1,4-DIHYDROPYRIDINES, A METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1991-12-24 | — | — | US | disclosed |